CAT and colorectal carcinoma: Our study establishes CPT1A as an effective biomarker to predict CRC prognosis and radiotherapy sensitivity and proposes the molecular mechanism by which it mediates radiosensitivity through the FOXM1-SOD1/SOD2/CAT axis.